Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle

François Lamoureux(Centre National de la Recherche Scientifique), Benjamin Ory(Centre National de la Recherche Scientifique)

Nature Communications

March 19, 2014

10.1038/ncomms4511

Cited by 145

Related Papers

Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1

|Oncotarget|2016|50

TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model

|EBioMedicine|2020|36

Tracking Targets of Dynamic Super-Enhancers <i>in Vitro</i> to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells

|Environmental Health Perspectives|2023|5